1 / 83

Egypt Home Healthcare Market Analysis Sample Report

The Egypt Home Healthcare Market is witnessing lucrative growth opportunities as the demand for high-quality home healthcare services increase in Egypt. The rising geriatric population and associated lifestyle diseases in Egypt are primarily responsible for the growth of the market. Alrazy Group and Manzil Home Health Services are some of the major players in the Egypt home healthcare market. To get a detailed report, contact us at - info@insights10.com

Insights4
Télécharger la présentation

Egypt Home Healthcare Market Analysis Sample Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. A sample report on Egypt Home Healthcare Market Analysis Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2022 – 2030F) www.insights10.com

  2. This report presents a strategic analysis of the Egypt Home Healthcare Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, types of clinical diagnostics, point-of-care testing, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Egypt Home Healthcare Market, and offers unmatched value, accuracy, and expert insights

  3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2022 Forecast Period 2023-2030 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Research Approach Secondary Research (60%), Primary Research (40%) Click on the icon to know the detailed methodology 3 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  4. Table of Content CONTENT PG. NO. 12-25 1. Home Healthcare Overview 1.1. Overview 1.2. Egypt Overview 1.3. Economic Overview: Egypt 1.4. Home Healthcare Market in Egypt 1.5. Healthcare Services Market in Egypt 1.6. Healthcare Scenario in Egypt 1.7. Health Insurance Coverage: Egypt 1.8. Budget of the Government for Public Insurance 1.9. Mergers and Acquisitions 26-33 2. Market Size and Forecasting 2.1 Market size and forecasts (Excel and Methodology) 4 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  5. Table of Content CONTENT PG. NO. 2.2. Market Segmentation 2.2.1. Device Type 2.2.2. Service Type 2.2.3. Indication Type 34-38 3. Market Dynamics 3.1. Market Growth Drivers 3.1.1. Egypt Home Healthcare Market Driver 1 3.1.2. Egypt Home Healthcare Market Driver 2 3.1.3. Egypt Home Healthcare Market Driver 3 3.2. Market Restraints 3.2.1. Egypt Home Healthcare Market Restraint 1 3.2.2. Egypt Home Healthcare Market Restraint 2 5 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  6. Table of Content CONTENT PG. NO. 3.2.3. Egypt Home Healthcare Market Restraint 3 39-49 4. Competitive Landscape 4.1. Major Market Share 4.2. Key Company Profile 4.2.1. Maxim Healthcare Services 4.2.1.1. Overview 4.2.1.2. Product Applications & Services 4.2.1.3. Recent Developments 4.2.1.4. Partnerships Ecosystem 4.2.1.5. Financials (Based on Availability) 4.2.2. Amedisys 4.2.2.1. Overview 6 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  7. Table of Content CONTENT PG. NO. 4.2.2.2. Product Applications & Services 4.2.2.3. Recent Developments 4.2.2.4. Partnerships Ecosystem 4.2.2.5. Financials (Based on Availability) 4.2.3. AccentCare 4.2.3.1. Overview 4.2.3.2. Product Applications & Services 4.2.3.3. Recent Developments 4.2.3.4. Partnerships Ecosystem 4.2.3.5. Financials (Based on Availability) 4.2.4. Bayada Home Health Care 4.2.4.1. Overview 7 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  8. Table of Content CONTENT PG. NO. 4.2.4.2. Product Applications & Services 4.2.4.3. Recent Developments 4.2.4.4. Partnerships Ecosystem 4.2.4.5. Financials (Based on Availability) 4.2.5. Interim HealthCare 4.2.5.1. Overview 4.2.5.2. Product Applications & Services 4.2.5.3. Recent Developments 4.2.5.4. Partnerships Ecosystem 4.2.5.5. Financials (Based on Availability) 4.2.6. Aveanna Healthcare 4.2.6.1. Overview 8 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  9. Table of Content CONTENT PG. NO. 4.2.6.2. Product Applications & Services 4.2.6.3. Recent Developments 4.2.6.4. Partnerships Ecosystem 4.2.6.5. Financials (Based on Availability) 4.2.7. VitalAire 4.2.7.1. Overview 4.2.7.2. Product Applications & Services 4.2.7.3. Recent Developments 4.2.7.4. Partnerships Ecosystem 4.2.7.5. Financials (Based on Availability) 4.2.8. Curexmed 4.2.8.1. Overview 9 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  10. Table of Content CONTENT PG. NO. 4.2.8.2. Product Applications & Services 4.2.8.3. Recent Developments 4.2.8.4. Partnerships Ecosystem 4.2.8.5. Financials (Based on Availability) 4.2.9. GE Healthcare 4.2.9.1. Overview 4.2.9.2. Product Applications & Services 4.2.9.3. Recent Developments 4.2.9.4. Partnerships Ecosystem 4.2.9.5. Financials (Based on Availability) 4.2.10. Royal HomeCare 4.2.10.1. Overview 10 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  11. Table of Content CONTENT PG. NO. 4.2.10.2. Product Applications & Services 4.2.10.3. Recent Developments 4.2.10.4. Partnerships Ecosystem 4.2.10.5. Financials (Based on Availability) 50-57 5. Reimbursement Scenario 5.1. Reimbursement Regulation 5.2. Reimbursement Process for Diagnosis 5.3. Reimbursement Process for Treatment 58-63 6. Methodology & Scope 11 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  12. Egypt Home Healthcare Market Analysis 1. Home Healthcare Overview

  13. 1.1 Statistics at a Glance: The Scenario of Home Healthcare in the World Scope of Home Healthcare Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 70% of the population using home healthcare services are aged 65 and older One-third of the persons requiring in- home care are under age 60 In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic ▪ $285 Mn virtual reality in medical and home health technology is valued at $285 Mn 42% North America dominates the global home healthcare share In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 13 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  14. 1.1 Statistics at a Glance: The Scenario of Home Healthcare in the World (continued) Europe ~Revenue to reach $XX Bn by 2027 North America ~ Market Size of $XX Bn Asia -Fastest CAGR Africa Egypt Market ~$XX Mn Market ~Market Size of $XX Bn 14 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  15. 1.2 Egypt Overview Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ 109 Mn Is the population of Egypt, in 2021 $404 Bn Is the Gross Domestic Product (GDP) in Egypt in 2021 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 30 Is the median age in Egypt, in 2022 $150 per capita was the amount of national health expenditures in 2021 15 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  16. 1.3 Economic Overview: Egypt Population of Egypt, (2020-2030) GDP of Egypt, (2020-2030) XX XX XX XX 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F Population Split (2023) In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ By Gender By Age Group In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 0-14 15-24 25-54 Male 49% Female 51% Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 55-64 65+ Illustrative Illustrative 16 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  17. 1.4 Statistics at a Glance: The Scenario of Home Healthcare in Egypt Scope of Home Healthcare Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 10.5% of the population in Egypt is 65 and above $1.01 Bn home healthcare market was valued at $1.01 Bn in Egypt in 2022 In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic in Egypt ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 936 certified home healthcare providers are there in Egypt 17-35 aged men and women are interested in becoming home healthcare professionals Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 17 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  18. 1.5 Healthcare Services in Egypt Egypt Healthcare Services Market Forecast, 2022-2030 (in $Bn) XX 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the overall Healthcare Services market in Egypt, which includes the market size, current trends and other details related to the topic ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 18 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  19. 1.6 Healthcare Scenario in Egypt Home Healthcare Drug Development Process: The process of developing a Home Healthcare drug is complex and involves many stages, from preclinical research to clinical trials to regulatory approval. Here is a simplified diagram of the Home Healthcare drug development process: Preclinical Research: Researchers identify potential drug candidates and test them in the lab Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating Home Healthcare Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and effectiveness Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market o o o o o FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and effectiveness. Here are four of these approaches: Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need ▪ Fast Track A process designed to expedite the development and review of drugs which may demonstrate substantial improvement over available therapy Breakthrough Therapy ▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved based on a surrogate endpoint Accelerated Approval ▪ Priority Review A Priority Review designation means FDA’s goal is to take action on an application within 6 months ▪ Illustrative Illustrative 19 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  20. 1.6 Healthcare Scenario: Home Healthcare Patient Journey Presentation Diagnosis Treatment Follow up Confirmatory Diagnosis Complete blood count (evaluate number & quality of RBCs, Hb & WBCs) Prevention and management of crisis: • For VOC and Splenic Sequestration: HU, Endari, Adakveo, Oxbryta • For infections: Antibiotics, Vaccines • Long term follow-up is required for patients with SCD • Annual assessment: CBC and reticulocyte count, iron status, liver and renal function tests, urinalysis, LDH, vitamin D level and neurocognitive assessment • ESOD (End Stage Organ Damage) evaluation starting from age 7 • Yearly Transcranial Doppler test to determine risk of stroke Initial Diagnosis Imaging (confirm bone related changes or respiratory problems) A suspected diagnosis is usually made, based on physical examination and detailed patient and family history Prenatal screening/ Neonatal screening Bacterial cultures of blood, sputum, urine, stool (detect any infection) Prevention and management of complications: Genetic testing (detect the type of SCD) • Stroke: Chronic transfusions, HU Stakeholders PCP, pediatrician, neonatologist, endocrinologist, cardiologist, hematologist, orthopedist, psychologist and psychiatrist PCP, paediatrician, neonatologist, haematologist and genetic counsellor PCP, pediatrician, medical geneticist, cardiologist, hematologist, endocrinologist, psychologist and psychiatrist PCP, pediatrician, medical geneticist, hematologist, gynecologist and pathologist Depending on the organ complications, the treatment involves different specialists at different times Illustrative Illustrative 20 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  21. 1.7 Health Insurance Coverage: Egypt % of People by Type of Health Insurance Coverage (2021) Number of People By Health Insurance Coverage Coverage Type 2020 2021 Change % 8.3 Uninsured Total 327,521 328,074 91.7 With health insurance Any health plan 299,230 300,887 0.4 Any private plan 217,896 216,366 –0.6 66.0 Any private plan Employment-based 178,737 178,285 –0.2 54.3 Employment-based Direct-purchase 33,869 33,555 –0.1 10.2 Direct-purchase Marketplace coverage 10,924 11,389 0.1 3.5 Marketplace TRICARE 9,165 8,299 –0.3 2.5 TRICARE Any public plan 112,925 117,095 1.2 Medicare 58,541 60,226 0.5 35.7 Any public plan 18.4 Medicare Medicaid 58,778 61,940 0.9 18.9 Medicaid VA and CHAMPVA 2,967 3,151 0.1 1.0 VA and CHAMPVA Uninsured 28,291 27,187 –0.4 In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year More people had private health insurance (66%) than public coverage (35.7%) Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) ▪ ▪ ▪ Illustrative Illustrative 21 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  22. 1.8 Budget of Egypt Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 Medicare In Billions Of Dollars $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926 Medicaid 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% Medicare As % Of GDP 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4% Medicaid National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE ▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% oftotal NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 22 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  23. 1.9 Mergers and Acquisitions RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend $16.7 112 110 107 107 89 82 $11.7 $10.5 $7.7 $6.8 $6.0 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 Buyer Composition: Strategic Vs Financial (2020) Buyer Type by Deal Size ($Mn) 39% 41% 41% 42% 58% 59% 59% 61% Strategic Buyers Financial Buyers $0- $25 $25-$50 $50-$100 $100+ 57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 Illustrative Illustrative 23 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  24. 1.9 Mergers and Acquisitions (continued) Latest Deals In Egypt Amount / Duration Company Name Type Year Key Pointers Oracle’s acquisition of Cerner is big tech’s latest foray into the healthcare system, promising better outcomes Oracle acquire Cerner through an all-cash tender offer for $95.00 per share, or approximately $28.3 Bn in equity value Cerner is a leading provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better healthcare to individual patients and communities ▪ ▪ Acquisition $28.3 Bn June, 2022 ▪ Oracle acquisition of Cerner GSK has acquire BELLUS for US$14.75 per share of common stock in cash representing an approximate total equity value of US$2.0 billion ▪ BELLUS is a late-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough ▪ Acquisition $2 Bn April 2023 Acquisition further strengthens specialty medicines and respiratory pipeline with camlipixant, a highly selective P2X3 antagonist and potential best-in-class treatment for refractory chronic cough ▪ GSK acquisition of BELLUS Health Illustrative Illustrative 24 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  25. 1.9 Mergers and Acquisitions(continued) Latest Deals In Egypt Amount / Duration Company Name Type Year Key Pointers Merger March 2023 Merger Jan 2023 25 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  26. Egypt Home Healthcare Market Analysis 2. Market Size and Forecasting

  27. 2.1 Market size and forecasts (Excel and Methodology) Click on the icon to know the methodology and assumption Egypt Home Healthcare Market Forecast, 2022-2030 (in $Bn) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ XX XX In this section you will get an understanding of the overall Healthcare Insurance market in Malaysia, which includes the market size, current trends and other details related to the topic ▪ 2022 2023F 2024F 2025F 2026F 2025 2027F 2026 2028F 2027 2029F 2030F 2023 2024 2028 2029 2030 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Major Markets Patient (Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Egypt Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative ▪ % of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Egypt Market Size (Bn $) 61 74 84 87 91 95 99 106 27 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  28. 2.2 Snapshot of Home Healthcare Market Segmentation Indication Type Cardiovascular Disorders & Hypertension Device Type Service Type Testing, Screening, and Monitoring Device Therapeutic Home Healthcare Devices Skilled Nursing Services Rehabilitation Therapy Services Hospice and Palliative Care Services Diabetes Respiratory Diseases Mobility Assist Unskilled Care Services Pregnancy Respiratory Therapy Services Mobility Disorders Infusion Therapy Services Hearing Disorders Pregnancy Care Services Home Healthcare Wound Care In this section you will get an understanding of the segmentations which will cover the Egypt Home Healthcare Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 28 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  29. 2.2.1 Market Segmentation: By Device Type Egypt Home Healthcare Market Share, By Device Type (2022) Testing, screening and monitoring device market in Egypt is a significant component of the overall home healthcare treatment market ▪ Mobility Assist It has the maximum market share in Egypt Home Healthcare market with approximately xx% ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Testing, Screening, and Monitoring Device Therapeutic Home Healthcare Devices In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 29 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  30. 2.2.2 Market Segmentation: By Service Type Egypt Home Healthcare Market Share, By Service Type (2022) Skilled nursing services market in Egypt is a significant component of the overall home healthcare market ▪ Pregnancy Care Services Infusion Therapy Services It has the maximum market share in Egypt home healthcare market with approximately xx% ▪ Respiratory Therapy Services Skilled Nursing Services Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Unskilled Care Services In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Hospice and Palliative Care Services Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Rehabilitation Therapy Services 30 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  31. 2.2.3 Market Segmentation: By Indication Type Egypt Home Healthcare Market Share, By Indication Type (2022) Cardiovascular disorders and hypertension have the maximum market share in Egypt home healthcare market with approximately xx% ▪ Wound Care Cancer Hearing Disorders Cardiovascular Disorders & Hypertension Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Mobility Disorders In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Pregnancy Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Diabetes Respiratory Diseases 31 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  32. Egypt Home Healthcare Market Analysis 3. Market Dynamics

  33. 3.1 Market growth drivers 3.1.1 Incidence of Home Healthcare is increasing in Egypt, with more than 1.8 Mn new Home Healthcare cases expected to be diagnosed in 2023 Incidence of Home Healthcare is increasing in Egypt, with more than 1.8 Mn new Home Healthcare cases expected to be diagnosed in 2023 ▪ Incidence of Home Healthcare in Egypt This is driving the demand for Home Healthcare treatments and creating opportunities for growth in the Home Healthcare market ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 33 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  34. 3.1 Market growth drivers (continued) 3.1.2 Death rate from Home Healthcare in Egypt has declined by 31% from 1992 to 2022, largely due to advances in technology and treatment options Top countries that are leveraging technology for Home Healthcare Egypt has a long history of investing in Home Healthcare research and treatment, and as a result, has become a world leader in the field ▪ Norway IT has a robust healthcare infrastructure, including world- renowned research institutions, hospitals, and clinics, that are dedicated to Home Healthcare treatment and research ▪ Austria Denmark Belgium Spain One of the key factors that has allowed Egypt to stay ahead in the field of Home Healthcare research and treatment is the high level of investment in Home Healthcare-related research ▪ Italy Netherlands Sweden Singapore Switzerland Israel In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Australia Canada France Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ United Kingdom China South Korea Germany Japan United States Illustrative Illustrative 34 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  35. 3.1 Market growth drivers (continued) 3.1.3 In 2021, the National Home Healthcare Institute (NCI) received $6.4 Bn in funding from Egypt federal government to support Home Healthcare research and training programs Fundings from government and other organizations Egypt government provides significant support and funding for Home Healthcare research and treatment, which is driving innovation and growth in the Home Healthcare market ▪ Source Year Fund ($) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ National Home Healthcare Institute (NCI) 2021 $ 6.4 Bn In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Centers for Disease Control and Prevention (CDC) 2021 $ 501 Mn Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ American Home Healthcare Society (ACS) 2020 $ 150 Mn Susan G. Komen 2020 $ 98 Mn Illustrative Illustrative 35 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  36. 3.2 Market restraints 3.2.1 In 2020, the average cost of a new Home Healthcare drug was over $150,000 per year 3.2.2 Average cost of developing a new Home Healthcare set up by regulatory body is over $2.6 Bn 3.2.3 Demand for Home Healthcare care is expected to increase by 42% by 2025, while the supply of oncologists is only expected to increase by 28% Home Healthcare treatments can be very expensive and can lead to financial burden for patients and healthcare systems Cost of Home Healthcare treatment varies depending on the type of Home Healthcare, stage of Home Healthcare, and treatment options Some common Home Healthcare treatments, such as chemotherapy and radiation therapy, can cost tens of thousands of dollars Regulatory requirements for Home Healthcare treatments can be very stringent, which can slow down the approval process and limit access to new treatments Regulatory bodies, such as Egypt Food and Drug Administration (FDA), require extensive clinical trials and safety data before approving new Home Healthcare treatments This can be a lengthy and costly process, which can delay the availability of new treatments for patients There is a shortage of oncologists in Egypt, which can limit access to Home Healthcare treatments and create barriers to growth in the Home Healthcare market Oncologists are physicians who specialize in the diagnosis and treatment of Home Healthcare With the aging population and the increasing incidence of Home Healthcare, there is a growing demand for oncologists However, the supply of oncologists is not keeping pace with the demand Illustrative Illustrative ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. 36 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  37. Egypt Home Healthcare Market Analysis 4. Competitive Landscape

  38. 4.1 Major Market Share Revenue of Major players in Egypt Home Healthcare Market ($ Mn) Egypt Home Healthcare market is a highly competitive space, with many companies developing and marketing Home Healthcare treatments ▪ Other Some of the top companies in Egypt Home Healthcare market based on revenue and market share include ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ XX Illustrative Illustrative 38 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  39. 4.2 Key Company Profile Key Note: Maxim Healthcare Services 1 Here is the list of top 10 companies which will cover in the final report ▪ 2 Amedisys Each company will have slides for ▪ 3 Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report AccentCare o o Bayada Home Health Care 4 o o 5 Interim HealthCare o 6 o Aveanna Healthcare o 7 VitalAire o 8 Curexmed ▪ 9 GE Healthcare ▪ 10 Royal HomeCare 39 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  40. 4.2.1 Maxim Healthcare Services Solutions offered by Maxim Founded in: 1988 ▪ Maxim offers private duty nursing, skilled nursing, physical rehabilitation, personal care, respite care, and behavioral care for individuals with chronic and acute illnesses and disabilities ▪ At Maxim, giving patients and their families excellent care is the main goal. Patients of all ages receive assistance from a team of nurses, therapists, and home health aides in maintaining their quality of life ➢ Pediatrics HQ: Maryland, US ➢ Autism Type: Private ➢ Adults Revenue: $55 Mn ➢ Military and Federal Website: maximhealthcare.com ➢ Private Duty Nursing Recent Activity / Press Coverage Expansion of Applied BehavioralAnalysis (ABA) therapy services in Tampa and Raleigh was announced by home health firm Maxim Healthcare Services Matthew Sticklin was recently appointed as the organization's Chief Financial Officer by Maxim Healthcare Services The umbrella company Maxim Healthcare Group stated that it has split its two business sections into distinct, independently run businesses called Maxim Healthcare Services and Maxim Healthcare Staffing 40 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  41. 4.2.1 Maxim Healthcare Services (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners One of the largest pharmaceutical distributors in the United States, McKesson has been a long-standing distribution partner for Maxim Maxim has been working with SAP, a leading software company, to develop digital solutions for its healthcare products A leading Swiss biotechnology company, Lonza provides Maxim with contract manufacturing services for the production of its biologics and pharmaceuticals Cardinal Health is a Fortune 500 healthcare services company that provides pharmaceutical distribution services to Maxim It is one of the largest drugstore chains in the United States and Europe, and its extensive network of retail locations and distribution centers make it an important distribution partner for Maxim Maxim has a strategic partnership with Microsoft to leverage its cloud computing and AI technologies in the development of new healthcare products Thermo Fisher Scientific is a leading provider of analytical instruments, reagents, and laboratory services A leading healthcare services provider in Asia, Zuellig Pharma is a distribution partner for Maxim in several Asian countries GE Healthcare provides Maxim with advanced medical imaging and diagnostics technologies, including CT scanners and MRI machines Illustrative Illustrative One of the largest pharmaceutical wholesalers in Europe, PHOENIX Group distributes Maxim's products in several European countries 41 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  42. 4.2.1 Maxim Healthcare Services (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Maxim and Lilly will collaborate on the development of Maxim Diagnostics’ Elecsys Amyloid Plasma Panel Elecsys Amyloid Plasma Panel has demonstrated clinical performance and is currently undergoing additional investigation to ensure clinical validation Once approved, could help healthcare professionals to streamline the journey to diagnosis for more patients ▪ ▪ Collaboration - March, 2023 Lilly ▪ Maxim to acquire GenMark Diagnostics for US$ 24.05 per share with the expectation to close in the 2nd quarter of 2021 ▪ GenMark provides molecular diagnostic tests that are designed to detect multiple pathogens from a single patient sample ▪ Merger $1.8 Bn March 2021 GenMark Diagnostics GenMark’s ePlex platform delivers rapid and actionable results so clinicians can determine the cause of infection and the most effective treatment, potentially saving lives and alleviating the healthcare burden ▪ Illustrative Illustrative 42 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  43. 4.2.1 Maxim Healthcare Services (continued) Revenues ($Bn), 2020-2030 According to Maxim's 2020 financial report, the company had sales of CHF 58.3 Bn (Swiss Francs) in 2020 ▪ This is equivalent to approximately $63.3 Bn USD, based on exchange rates at the end of 2020 ▪ XX Company's Pharmaceuticals Division generated sales of CHF 49.9 Bn in 2020, while the Diagnostics Division generated sales of CHF 8.4 Bn ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2022 Revenue generated by Maxim in 2020 reflects the company's continued growth and success in the healthcare industry ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 1 2 3 4 Illustrative Illustrative 43 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  44. 4.2.2 Company 2 Solutions offered by Company Founded in: HQ: Type: Revenue: Website: Drugs for Home Healthcare Recent Activity / Press Coverage Drugs Indications Illustrative Illustrative 44 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  45. 4.2.2 Company 2 (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners Illustrative Illustrative 45 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  46. 4.2.2 Company 2 (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Illustrative Illustrative 46 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  47. 4.2.2 Company 2 (continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ xx xx xx In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 Illustrative Illustrative 47 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  48. Egypt Home Healthcare Market Analysis 5. Reimbursement Scenario

  49. 5.1 Reimbursement Regulation Medicare and Medicaid together provide health insurance coverage for more than 4 in 10 Americans The reimbursement scenario in the US Home Healthcare market is complex and can vary depending on the specific treatment, setting of care, and insurance coverage. Here are some key points to consider: Medicare: o ▪ Medicare is a federal health insurance program for people aged 65 and older, as well as people with certain disabilities or health conditions Medicare covers many Home Healthcare treatments, including chemotherapy, radiation therapy, and some immunotherapies However, coverage can be subject to strict guidelines and restrictions, such as the requirement for prior authorization Medicaid: o Medicaid is a joint federal-state program that provides health insurance for people with low incomes o Medicaid coverage for Home Healthcare treatments can vary by state, and may be subject to limits on the amount and type of treatment covered Private Insurance: o Private insurance coverage for Home Healthcare treatments can also vary widely depending on the insurer and the specific policy o Some policies may have high out-of-pocket costs, such as deductibles and co-pays, while others may have more comprehensive coverage Other Public 1% o Other Private 3% Uninsured 9% Medicare 17% o ▪ Medicaid and CHIP 21% ▪ Employer-Sponsored 49% Health Insurance Coverage, 2022 Illustrative Illustrative 49 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

  50. 5.1 Reimbursement Regulation (continued) Affordable Care Act: Affordable Care Act (ACA) includes provisions to help improve access to Home Healthcare treatments by requiring insurers to cover certain preventive services, including Home Healthcare screenings, without co-pays or deductibles It also includes protections for people with pre-existing conditions, such as Home Healthcare Reimbursement for New Treatments: Reimbursement for new Home Healthcare treatments can be a complex and lengthy process, as insurers and government programs often require evidence of safety and effectiveness before providing coverage This can create challenges for companies developing and marketing new treatments Value-Based Care: There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the value of treatments rather than simply the volume of treatments Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics ▪ o o ▪ o o ▪ o o In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative 50 A Sample Report on Egypt Home Healthcare Market Analysis I Confidential

More Related